Director, Global Scientific Communications, Hematology

Director, Global Scientific Communications, Hematology

Location: Boston, MA (Seaport) onsite. This role follows AstraZeneca’s in-office expectation, averaging a minimum of three days per week onsite. Fully remote work is not offered.

Reports to: Senior Director, Global Medical Communications, Hematology, Nephrology & Transplant

Organization: Alexion, AstraZeneca Rare Disease

Alexion, AstraZeneca Rare Disease is seeking a Director, Global Scientific Communications, Hematology to lead global scientific communications strategy, publication planning, and medical education for a high-impact Hematology portfolio across key lifecycle stages in Boston, one of the world’s most competitive life sciences markets.

This role combines the scale and scientific credibility of a global biopharmaceutical organization with the urgency, focus, and patient proximity of rare disease. The successful candidate will help shape how Alexion/AstraZeneca communicates complex science, clinical value, and patient impact to healthcare professionals, external experts, and the broader medical community.

The Director will chair the Hematology Global Publication Team and serve as a senior scientific communications partner accountable for driving decisions, aligning cross-functional stakeholders, and moving publication and medical education priorities forward. This role requires a self-starter who can operate independently, manage ambiguity, challenge assumptions, push back constructively, and negotiate trade-offs with internal and external partners when needed.

Boston offers deep access to academic medicine, clinical research, biotech innovation, and specialized scientific talent. In a market where candidates have many choices, this opportunity stands out for leaders who want more than proximity to innovation. It offers the chance to influence global evidence communication for rare disease patients, partner across a scaled R&D and medical organization and help define how meaningful science reaches clinicians and communities worldwide.

Unlike many smaller biotech environments where communications leaders may be limited by a single asset, narrow funding horizon, or build-from-scratch infrastructure, this role offers strategic ownership, enterprise resources, global reach, mature publication governance, and the opportunity to contribute across an established rare disease platform.

In this role, you will:

• Lead global scientific communications strategy: Develop communications strategies and publication plans for assigned Hematology products and indications, aligned with global medical, brand, and corporate priorities.
• Chair Global Publication Teams: Lead Global Publication Team meetings and activities, drive agenda priorities, facilitate decisions, resolve stakeholder misalignment, and ensure clear ownership of next steps.
• Exercise independent judgment: Make informed recommendations, elevate only when appropriate, and independently negotiate timelines, resources, authorship considerations, agency deliverables, and competing stakeholder priorities while maintaining scientific integrity and compliance.
• Deliver scientific communications: Lead timely development of abstracts, posters, oral presentations, manuscripts, slide decks, and related scientific deliverables.
• Develop medical education initiatives: Plan and implement congress symposia and other scientific programs that communicate important information to medical and scientific audiences.
• Manage
  cross-functional partnerships: Build strong relationships across Global Medical Communications, Medical Affairs, clinical, biostatistics, product, agency, and other internal teams. Influence without direct authority and constructively challenge partners when scientific, operational, or compliance risks arise.

This is an opportunity to influence the global scientific narrative for a Hematology portfolio addressing significant unmet patient needs. You will connect publication and medical education plans to medical objectives, evolving data, competitive dynamics, and clinical practice across global markets. Success requires…